PureTech Health LLC's Form 4 filing
Gelesis Holdings, Inc.GLSH · filed May 31, 2023
- Accession no.
- 0000899243-23-014169
- Filed
- May 31, 2023, 5:30 PM ET
- Trade date
- May 26, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 derivative transactions. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| PureTech Health LLCCIK 0001727395 | 10% Owner |
| PureTech Health plcCIK 0001782999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2023 | Common Stock | PPurchaseAcquired | +24,647,887 | $350,000.00 | – | – | Indirect | Price outlier |
| May 26, 2023 | Common Stock | PPurchaseAcquired | +43,133,803 | –F1 | – | 43,133,803 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The warrants were issued in connection with the purchase of the convertible note purchases reported herein.
Referenced by the price of 1 transaction in Table II.